186 related articles for article (PubMed ID: 3958917)
1. Mixing-tank model for predicting dissolution rate control or oral absorption.
Dressman JB; Fleisher D
J Pharm Sci; 1986 Feb; 75(2):109-16. PubMed ID: 3958917
[TBL] [Abstract][Full Text] [Related]
2. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
3. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs.
Macheras P; Iliadis A; Melagraki G
Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862
[TBL] [Abstract][Full Text] [Related]
4. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
[TBL] [Abstract][Full Text] [Related]
5. Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation.
Takano R; Furumoto K; Shiraki K; Takata N; Hayashi Y; Aso Y; Yamashita S
Pharm Res; 2008 Oct; 25(10):2334-44. PubMed ID: 18560998
[TBL] [Abstract][Full Text] [Related]
6. Dissolution Kinetics of a BCS Class II Active Pharmaceutical Ingredient: Diffusion-Based Model Validation and Prediction.
Gao Y; Glennon B; He Y; Donnellan P
ACS Omega; 2021 Mar; 6(12):8056-8067. PubMed ID: 33817465
[TBL] [Abstract][Full Text] [Related]
7. Use of rabbits for GI drug absorption studies: relationship between dissolution rate and bioavailability of griseofulvin tablets.
Maeda T; Takenaka H; Yamahira Y; Noguchi T
J Pharm Sci; 1979 Oct; 68(10):1286-9. PubMed ID: 512862
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.
Wong SM; Kellaway IW; Murdan S
Int J Pharm; 2006 Jul; 317(1):61-8. PubMed ID: 16647232
[TBL] [Abstract][Full Text] [Related]
9. An integrated model for determining causes of poor oral drug absorption.
Yu LX
Pharm Res; 1999 Dec; 16(12):1883-7. PubMed ID: 10644078
[TBL] [Abstract][Full Text] [Related]
10. Guidance in the setting of drug particle size specifications to minimize variability in absorption.
Johnson KC; Swindell AC
Pharm Res; 1996 Dec; 13(12):1795-8. PubMed ID: 8987073
[TBL] [Abstract][Full Text] [Related]
11. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical model for dose-dependent drug absorption.
Dressman JB; Fleisher D; Amidon GL
J Pharm Sci; 1984 Sep; 73(9):1274-9. PubMed ID: 6548523
[TBL] [Abstract][Full Text] [Related]
13. Computational oral absorption simulation of free base drugs.
Sugano K
Int J Pharm; 2010 Oct; 398(1-2):73-82. PubMed ID: 20655999
[TBL] [Abstract][Full Text] [Related]
14. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study.
Fujioka Y; Kadono K; Fujie Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
J Control Release; 2007 Jun; 119(2):222-8. PubMed ID: 17442444
[TBL] [Abstract][Full Text] [Related]
15. Fast-dissolving microparticles fail to show improved oral bioavailability.
Wong SM; Kellaway IW; Murdan S
J Pharm Pharmacol; 2006 Oct; 58(10):1319-26. PubMed ID: 17034654
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of drugs: the digoxin dilemma.
Greenblatt DJ; Smith TW; Koch-Weser J
Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug.
Fujioka Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
Int J Pharm; 2008 Mar; 352(1-2):36-43. PubMed ID: 18037251
[TBL] [Abstract][Full Text] [Related]
18. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
19. In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs.
Kataoka M; Masaoka Y; Yamazaki Y; Sakane T; Sezaki H; Yamashita S
Pharm Res; 2003 Oct; 20(10):1674-80. PubMed ID: 14620525
[TBL] [Abstract][Full Text] [Related]
20. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.
Wagner C; Jantratid E; Kesisoglou F; Vertzoni M; Reppas C; B Dressman J
Eur J Pharm Biopharm; 2012 Sep; 82(1):127-38. PubMed ID: 22652546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
